International Journal of Biological Macromolecules, Journal Year: 2024, Volume and Issue: 275, P. 133655 - 133655
Published: July 3, 2024
Language: Английский
International Journal of Biological Macromolecules, Journal Year: 2024, Volume and Issue: 275, P. 133655 - 133655
Published: July 3, 2024
Language: Английский
Signal Transduction and Targeted Therapy, Journal Year: 2024, Volume and Issue: 9(1)
Published: Oct. 11, 2024
The cascade of metastasis in tumor cells, exhibiting organ-specific tendencies, may occur at numerous phases the disease and progress under intense evolutionary pressures. Organ-specific relies on formation pre-metastatic niche (PMN), with diverse cell types complex interactions contributing to this concept, adding a new dimension traditional cascade. Prior metastatic dissemination, as orchestrators PMN formation, primary tumor-derived extracellular vesicles prepare fertile microenvironment for settlement colonization circulating cells distant secondary sites, significantly impacting cancer progression outcomes. Obviously, solely intervening sites passively after macrometastasis is often insufficient. Early prediction holistic, macro-level control represent future directions therapy. This review emphasizes dynamic intricate systematic alterations that progresses, illustrates immunological landscape creation, deepens understanding treatment modalities pertinent metastasis, thereby identifying some prognostic predictive biomarkers favorable early predict occurrence design appropriate combinations.
Language: Английский
Citations
21Separation and Purification Technology, Journal Year: 2024, Volume and Issue: unknown, P. 129848 - 129848
Published: Sept. 1, 2024
Language: Английский
Citations
18Cell Reports Medicine, Journal Year: 2025, Volume and Issue: unknown, P. 101920 - 101920
Published: Jan. 1, 2025
Metabolic reprogramming of tumor cells is an emerging hallmark cancer. Among all the changes in cancer metabolism, increased glucose uptake and accumulation lactate under normoxic conditions (the "Warburg effect") a common feature cells. In this study, we develop lactate-responsive drug delivery platform by targeting Warburg effect. We design test gold/mesoporous silica Janus nanoparticle system as gated carrier, which gold particles are functionalized with oxidase capped α-cyclodextrin through surface arylboronate modification. presence lactate, generates hydrogen peroxide, induces self-immolation reaction arylboronate, leading to uncapping release. Our results demonstrate greatly improved specificity therapeutic efficacy for treatment different cancers. findings present effective approach metabolic tumors.
Language: Английский
Citations
2Journal of Translational Medicine, Journal Year: 2024, Volume and Issue: 22(1)
Published: Sept. 30, 2024
Language: Английский
Citations
12Advanced Materials, Journal Year: 2024, Volume and Issue: 36(27)
Published: April 21, 2024
Abstract Therapy‐induced immunogenic cell death (ICD) can initiate both innate and adaptive immune responses for amplified anti‐tumor efficacy. However, dying cell‐released ICD signals are prone to being sequestered by the TIM‐3 receptors on dendritic (DC) surfaces, preventing surveillance. Herein, dismantlable coronated nanoparticles (NPs) fabricated as a type of spatiotemporally controlled nanocarriers coupling tumor cell‐mediated induction DC‐mediated sensing. These NPs loaded with an inducer, mitoxantrone (MTO), wrapped redox‐labile anti‐TIM‐3 (αTIM‐3) antibody corona, forming separable core–shell structure. The corona disintegrates under high levels extracellular reactive oxygen species in microenvironment, exposing MTO‐loaded NP core releasing functional αTIM‐3 molecules DC sensitization. Systemic administration augments maturation, promotes cytotoxic T recruitment, enhances susceptibility checkpoint blockade, prevents side effects MTO. This study develops promising nanoplatform unleash potential host immunity cancer therapy.
Language: Английский
Citations
10Advanced Functional Materials, Journal Year: 2024, Volume and Issue: unknown
Published: July 31, 2024
Abstract Zwitterionic hydrogels with exceptional antifouling properties and biocompatibility have gained widespread attention in biomedical applications. However, achieving robust mechanical performance while maintaining high water content within a single‐network zwitterionic hydrogel remains challenging. Traditional covalent crosslinking strategies often lead to brittleness irreversible damage. Herein, novel acylsemicarbazide‐containing carboxybetaine methacrylate (ACBMA) monomer is designed synthesized that enables the construction of pure poly(ACBMA) (pACBMA) without chemical crosslinkers. The pACBMA exhibits exceeding 95% superior properties, including compressive fracture stress 3.92 MPa, strain up 99% breaking, toughness 212 ± 2.4 kJ m − 3 , outperforming chemically crosslinked poly(carboxybetaine methacrylate) (pCBMA) hydrogel. Additionally, excellent injectability, moldability, even recyclability through preparation microgels. Through unique molecular design, integrates multiple non‐covalent interactions, hydrogen bonding, electrostatic polymer chain entanglement, steric hindrance α ‐methyl group. These interactions synergistically contribute combination hydration, robustness, dynamic tunability. results provide new design strategy for constructing high‐performance promising potential diverse
Language: Английский
Citations
8Chinese Chemical Letters, Journal Year: 2024, Volume and Issue: unknown, P. 110012 - 110012
Published: May 1, 2024
Language: Английский
Citations
5Acta Biomaterialia, Journal Year: 2024, Volume and Issue: 184, P. 186 - 200
Published: June 25, 2024
Language: Английский
Citations
5International Journal of Biological Macromolecules, Journal Year: 2024, Volume and Issue: 283, P. 137707 - 137707
Published: Nov. 18, 2024
Language: Английский
Citations
4International Journal of Nanomedicine, Journal Year: 2025, Volume and Issue: Volume 20, P. 181 - 197
Published: Jan. 1, 2025
Abstract: The microenvironment tends to be immunosuppressive during tumor growth and proliferation. Immunotherapy has attracted much attention because of its ability activate tumor-specific immune responses for killing. cyclic GMP-AMP synthase-stimulator interferon genes (cGAS-STING) pathway is an innate that activates antitumor immunity by producing type I interferons. Cyclic dinucleotides (CDNs), produced cGAS sensing cytoplasmic abnormal DNA, are major intermediate activating molecules in the STING pathway. Nowadays, CDNs their derivatives have widely worked as powerful agonists immunotherapy. However, clinical translation hindered negative electrical properties, sensitivity hydrolytic enzymes, systemic toxicity. Recently, various CDN delivery systems made significant progress addressing these issues, either through monotherapy or combination with other treatment modalities. This review details recent advances CDNs-based pharmaceutical development strategies enriching at sites Keywords: dinucleotides, stimulator pathway, immunotherapy
Language: Английский
Citations
0